Pharmacytimes: Condition Center: Heart Failure http://www.pharmacytimes.com/condition-resources/heart-failure/condition-rss Heart Failure en-us Wed, 29 Mar 2017 10:54:13 UTC Wed, 29 Mar 2017 10:54:13 UTC Pharmacists and Heart Failure: Room for Intervention in Every Practice Setting http://www.pharmacytimes.com/resource-centers/heart-failure/pharmacists-and-heart-failure-room-for-intervention-in-every-practice-setting Heat failure (HF) caused 1 in 9 deaths in the United States in 2009.&nbsp; 1:26 PM, Tue March 28, 2017 FDA Accepts NDA for Investigational Hypertension Drug http://www.pharmacytimes.com/product-news/fda-accepts-nda-for-investigational-hypertension-drug The FDA has accepted&nbsp;the new drug application (NDA) for EZR-201, an investigational product from Ezra Innovations for the treatment of hypertension and heart failure.&nbsp; 10:23 AM, Fri January 20, 2017 Heart Failure Risk Reduction Strategies and Transition of Care http://www.pharmacytimes.com/resource-centers/heart-failure/heart-failure-risk-reduction-strategies-and-transition-of-care-introduction In this clip, Dr. Peter Salgo,<strong> </strong>a professor of medicine and anesthesiology at Columbia University College of Physicians and Surgeons; and an associate director of Surgical Intensive Care at New York-Presbyterian Hospital discusses heart failure.&nbsp; 4:17 PM, Thu December 29, 2016 Flashcards and QR Codes Improve Medication Adherence in Patients with Diabetes, Hypertension, and Heart Failure http://www.pharmacytimes.com/resource-centers/diabetes/flashcards-and-qr-codes-improve-medication-adherence-in-patients-with-diabetes-hypertension-and-heart-failure Poor medication adherence contributes to 125,000 deaths annually, causes up to half of all treatment failures, and costs the US healthcare system $100 billion each year. 9:00 AM, Tue November 15, 2016 Heart Failure Treatment Strategies for Patients with Diabetes http://www.pharmacytimes.com/resource-centers/diabetes/heart-failure-treatment-strategies-for-patients-with-diabetes The incidence of heart failure is increasing as the world’s population ages and the rates of other, often comorbid, diseases (eg, diabetes, heart disease, obesity) increase. 8:00 AM, Tue October 25, 2016 Is It Time to Move On From Tolvaptan for Acute Heart Failure? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/09/is-it-time-to-move-on-from-tolvaptan-for-acute-heart-failure This article summarizes recent literature surrounding the use of tolvaptan for acute heart failure. 4:30 AM, Wed September 28, 2016 Are ACE Inhibitors Interchangeable? http://www.pharmacytimes.com/contributor/thomas-szymanski-pharmd-candidate-2017/2016/09/are-ace-inhibitors-interchangeable That is, are they all equally effective? 10:04 PM, Mon September 19, 2016 Could CoQ10 Benefit Heart Failure Patients? http://www.pharmacytimes.com/resource-centers/heart-failure/could-coq10-benefit-heart-failure-patients Supplemental coenzyme Q10 may be a management option for patients with heart failure. 8:57 AM, Tue August 9, 2016 FDA Approves First Lisinopril Oral Solution http://www.pharmacytimes.com/product-news/fda-approves-first-lisinopril-oral-solution The FDA has approved Silvergate Pharmaceuticals’ Qbrelis, the first lisinopril oral solution. 8:00 AM, Fri August 5, 2016 Heart Failure Therapy: The Good, the Bad, and the Ugly http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/08/heart-failure-therapy-the-good-the-bad-and-the-ugly This article highlights the latest literature surrounding both new and old heart failure therapies. 9:52 PM, Tue August 2, 2016 Common Medications Can Trigger Heart Failure http://www.pharmacytimes.com/resource-centers/heart-failure/common-medications-can-trigger-heart-failure The American Heart Association has released a scientific statement cautioning against the use of some common drugs and supplements in patients with heart failure. 10:04 PM, Sun July 17, 2016 Should SSRIs Be Prescribed for Depression in Heart Failure Patients? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/07/should-ssris-be-prescribed-for-depression-in-heart-failure-patients Depression affects 10% to 40% of patients with heart failure, depending on disease severity. 8:38 AM, Fri July 8, 2016 Why Entresto Is a Winner for Heart Failure http://www.pharmacytimes.com/contributor/mel-seabright-pharmd-mba/2016/07/why-entresto-is-a-winner-for-heart-failure Two new analyses have further cemented Entresto’s place in heart failure therapy. 10:24 PM, Mon July 4, 2016 Can Vitamin D Supplementation Benefit Heart Failure Patients? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/06/can-vitamin-d-supplementation-benefit-heart-failure-patients This article explores recent evidence describing the potential benefits of vitamin D supplementation in patients with heart failure and reduced ejection fraction. 11:44 PM, Sun June 5, 2016 Heart Failure Guideline Update Puts Trust in Entresto http://www.pharmacytimes.com/contributor/imran-chughtai-pharmd/2016/06/heart-failure-guideline-update-puts-trust-in-entresto The American College of Cardiology, American Heart Association, and Heart Failure Society of America recently updated guidelines for pharmacological heart failure treatment, focusing specifically on 2 new agents. 9:44 PM, Wed June 1, 2016 Updated Heart Failure Guidelines Highlight Role of Entresto, Corlanor http://www.pharmacytimes.com/resource-centers/heart-failure/updated-heart-failure-guidelines-highlight-role-of-entresto-corlanor The American College of Cardiology, the American Heart Association, and the Heart Failure Society of America have updated heart failure guidelines to recommend the use of 2 medications: sacubitril/valsartan (Entresto) and ivabradine (Corlanor). 1:00 AM, Tue May 24, 2016 New Heart Failure Guidelines: What Pharmacists Need to Know http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/05/new-heart-failure-guidelines-what-pharmacists-need-to-know This article highlights the latest evidence from both the AHA/ACC and ESC guidelines, which were both published this past weekend. 9:10 PM, Sun May 22, 2016 Entresto Shows Benefit Even in Clinically Stable Heart Failure Patients http://www.pharmacytimes.com/resource-centers/heart-failure/entresto-shows-benefit-even-in-clinically-stable-heart-failure-patients Novartis’ sacubitril/valsartan (Entresto) is showing promise for heart failure patients with reduced ejection fraction, regardless of background therapy or clinical stability. 7:00 AM, Thu April 14, 2016 4 Heart Failure Management Tips for Community Pharmacists http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2016/02/4-heart-failure-management-tips-for-community-pharmacists the community pharmacist is in a unique position to provide another level of education to heart failure patients. 10:17 PM, Wed February 10, 2016 5 Things Pharmacists Should Know About Patients with Left Ventricular Assist Devices http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/02/5-things-pharmacists-should-know-about-patients-with-left-ventricular-assist-devices Left ventricular assist devices have emerged as a lifesaving treatment option for those with advanced heart failure. 10:08 PM, Tue February 9, 2016